title: ACR Appropriateness Criteria(®) Aggressive Nonmelanomatous Skin Cancer of the Head and Neck.
abstract: BACKGROUND
  Aggressive nonmelanomatous skin cancer (NMSC) of the head and neck presents an increasingly common therapeutic challenge for which prospective clinical trials are lacking.
  
  
  METHODS
  The American College of Radiology Appropriateness Criteria are evidence-based guidelines for specific clinical conditions that are reviewed every 3 years by a multidisciplinary expert panel. The guideline development and review include an extensive analysis of current medical literature from peer reviewed journals and the application of a well-established consensus methodology (modified Delphi) to rate the appropriateness of imaging and treatment procedures by the panel. In those instances in which evidence is lacking or not definitive, expert opinion may be used to recommend imaging or treatment.
  
  
  RESULTS
  The American College of Radiology Expert Panel on Radiation Oncology - Head and Neck Cancer developed consensus recommendations for guiding management of aggressive NMSC.
  
  
  CONCLUSIONS
  Multidisciplinary assessment is vital to guiding the ideal use of surgery, radiation, and systemic therapy in this disease.
authors.affiliation: Cleveland Clinic, Cleveland, Ohio.
authors.forename: Shlomo A
authors.initials: SA
authors.lastname: Koyfman
authors.affiliation: Maimonides Cancer Center, Brooklyn, New York.
authors.forename: Jay S
authors.initials: JS
authors.lastname: Cooper
authors.affiliation: Emory University School of Medicine, Atlanta, Georgia.
authors.forename: Jonathan J
authors.initials: JJ
authors.lastname: Beitler
authors.affiliation: Massachusetts General Hospital, Boston, Massachusetts.
authors.forename: Paul M
authors.initials: PM
authors.lastname: Busse
authors.affiliation: Radiologic Associates of Sacramento, Sacramento, California.
authors.forename: Christopher U
authors.initials: CU
authors.lastname: Jones
authors.affiliation: Indiana University School of Medicine, Indianapolis, Indiana.
authors.forename: Mark W
authors.initials: MW
authors.lastname: McDonald
authors.affiliation: Johns Hopkins University, Baltimore, Maryland.
authors.forename: Harry
authors.initials: H
authors.lastname: Quon
authors.affiliation: Fox Chase Cancer Center, Philadelphia, Pennsylvania, American College of Surgeons.
authors.forename: John A
authors.initials: JA
authors.lastname: Ridge
authors.affiliation: Emory University, Atlanta, Georgia, American Society of Clinical Oncology.
authors.forename: Nabil F
authors.initials: NF
authors.lastname: Saba
authors.affiliation: Duke University, Durham, North Carolina.
authors.forename: Joseph K
authors.initials: JK
authors.lastname: Salama
authors.affiliation: Henry Ford Health System, Detroit, Michigan.
authors.forename: Farzan
authors.initials: F
authors.lastname: Siddiqui
authors.affiliation: Montefiore Medical Center, Bronx, New York, American College of Surgeons.
authors.forename: Richard V
authors.initials: RV
authors.lastname: Smith
authors.affiliation: University of Michigan, Ann Arbor, Michigan, American Society of Clinical Oncology.
authors.forename: Francis
authors.initials: F
authors.lastname: Worden
authors.affiliation: University Hospitals Case Medical Center, Cleveland, Ohio.
authors.forename: Min
authors.initials: M
authors.lastname: Yao
authors.affiliation: University of California San Francisco, San Francisco, California.
authors.forename: Sue S
authors.initials: SS
authors.lastname: Yom
mesh_terms: D000970:Antineoplastic Agents / Q000627:therapeutic use; D002280:Basal Cell Carcinoma / Q000473:pathology / Q000628:therapy; D002294:Carcinoma, Squamous Cell / Q000473:pathology / Q000628:therapy; D006258:Head and Neck Neoplasms / Q000473:pathology* / Q000628:therapy*; D006801:Humans; D016867:Immunocompromised Host; D011879:Radiotherapy Dosage; D018714:Radiotherapy, Adjuvant; D012878:Skin Neoplasms / Q000473:pathology* / Q000628:therapy*
chemical_list: D000970:Antineoplastic Agents
keywords: Appropriateness Criteria; head neck; high risk; nonmelanomatous skin cancer; radiotherapy